Nifty
Sensex
:
:
16266.15
54326.39
456.75 (2.89%)
1534.16 (2.91%)

Pharmaceuticals & Drugs - Veterinary

Rating :
45/99

BSE: 524669 | NSE: HESTERBIO

2276.75
20-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  2341.00
  •  2416.95
  •  2182.00
  •  2329.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  31460
  •  704.40
  •  3105.00
  •  2131.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,937.06
  • 47.11
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,020.30
  • 0.44%
  • 7.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.73%
  • 3.20%
  • 31.93%
  • FII
  • DII
  • Others
  • 0.92%
  • 0.03%
  • 10.19%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.08
  • 11.73
  • 6.37

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.95
  • 10.85
  • 0.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.29
  • 7.89
  • -6.08

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.58
  • 44.43
  • 47.67

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 6.90
  • 7.88
  • 7.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 21.92
  • 24.21
  • 23.65

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
56.47
64.17
-12.00%
55.69
56.89
-2.11%
62.66
53.41
17.32%
60.19
39.85
51.04%
Expenses
46.14
44.40
3.92%
40.66
35.72
13.83%
45.10
37.61
19.91%
43.12
27.95
54.28%
EBITDA
10.33
19.78
-47.78%
15.03
21.18
-29.04%
17.56
15.80
11.14%
17.07
11.90
43.45%
EBIDTM
18.28%
30.82%
26.99%
37.22%
28.02%
29.59%
28.36%
29.86%
Other Income
7.19
2.48
189.92%
2.78
1.27
118.90%
1.42
0.24
491.67%
2.35
0.69
240.58%
Interest
1.50
1.44
4.17%
0.96
1.52
-36.84%
0.74
2.11
-64.93%
0.86
1.53
-43.79%
Depreciation
5.13
3.63
41.32%
5.17
3.27
58.10%
3.05
3.24
-5.86%
3.23
3.18
1.57%
PBT
10.89
13.87
-21.49%
11.68
17.66
-33.86%
15.19
10.69
42.10%
15.33
7.88
94.54%
Tax
2.30
3.77
-38.99%
3.35
4.79
-30.06%
4.06
4.01
1.25%
4.31
2.83
52.30%
PAT
8.58
10.10
-15.05%
8.33
12.87
-35.28%
11.13
6.68
66.62%
11.02
5.05
118.22%
PATM
15.20%
15.74%
14.96%
22.62%
17.76%
12.51%
18.31%
12.67%
EPS
9.08
11.39
-20.28%
9.97
14.51
-31.29%
12.49
7.85
59.11%
14.68
6.72
118.45%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
235.01
214.33
183.27
178.07
135.94
123.11
100.89
90.64
69.05
65.10
48.26
Net Sales Growth
9.65%
16.95%
2.92%
30.99%
10.42%
22.02%
11.31%
31.27%
6.07%
34.89%
 
Cost Of Goods Sold
62.72
50.23
27.98
28.47
23.31
28.45
19.75
25.32
11.39
15.42
7.75
Gross Profit
172.29
164.11
155.29
149.60
112.63
94.65
81.14
65.32
57.65
49.68
40.51
GP Margin
73.31%
76.57%
84.73%
84.01%
82.85%
76.88%
80.42%
72.07%
83.49%
76.31%
83.94%
Total Expenditure
175.02
145.67
127.87
110.03
88.68
82.09
67.50
65.90
44.60
43.21
29.66
Power & Fuel Cost
-
7.57
8.13
7.83
6.37
5.59
5.81
4.77
4.40
3.30
2.96
% Of Sales
-
3.53%
4.44%
4.40%
4.69%
4.54%
5.76%
5.26%
6.37%
5.07%
6.13%
Employee Cost
-
38.92
40.65
28.93
23.24
18.32
15.44
12.32
9.84
9.06
6.87
% Of Sales
-
18.16%
22.18%
16.25%
17.10%
14.88%
15.30%
13.59%
14.25%
13.92%
14.24%
Manufacturing Exp.
-
11.60
11.98
11.34
9.45
7.06
7.85
5.25
5.28
4.15
4.09
% Of Sales
-
5.41%
6.54%
6.37%
6.95%
5.73%
7.78%
5.79%
7.65%
6.37%
8.47%
General & Admin Exp.
-
15.29
13.47
13.72
13.81
11.47
10.23
8.90
7.23
6.09
4.76
% Of Sales
-
7.13%
7.35%
7.70%
10.16%
9.32%
10.14%
9.82%
10.47%
9.35%
9.86%
Selling & Distn. Exp.
-
15.02
18.97
16.77
9.11
8.15
6.77
7.14
4.87
4.34
2.68
% Of Sales
-
7.01%
10.35%
9.42%
6.70%
6.62%
6.71%
7.88%
7.05%
6.67%
5.55%
Miscellaneous Exp.
-
7.06
6.69
2.98
3.40
3.05
1.64
2.20
1.58
0.84
2.68
% Of Sales
-
3.29%
3.65%
1.67%
2.50%
2.48%
1.63%
2.43%
2.29%
1.29%
1.12%
EBITDA
59.99
68.66
55.40
68.04
47.26
41.02
33.39
24.74
24.45
21.89
18.60
EBITDA Margin
25.53%
32.03%
30.23%
38.21%
34.77%
33.32%
33.10%
27.29%
35.41%
33.63%
38.54%
Other Income
13.74
4.68
6.37
7.21
2.55
0.42
0.88
0.34
0.79
0.20
0.24
Interest
4.06
6.60
7.37
6.63
4.04
3.50
3.72
4.83
6.46
3.26
2.83
Depreciation
16.58
13.31
13.07
11.76
9.66
7.00
5.75
5.92
5.41
4.43
4.12
PBT
53.09
53.42
41.33
56.86
36.12
30.93
24.81
14.33
13.37
14.41
11.90
Tax
14.02
15.40
10.32
16.16
13.05
8.15
5.63
4.82
4.20
5.34
4.41
Tax Rate
26.41%
30.74%
24.97%
28.42%
36.13%
26.35%
22.69%
28.39%
31.41%
37.06%
37.06%
PAT
39.06
34.43
29.17
41.56
25.62
23.55
19.19
12.47
9.45
9.26
7.61
PAT before Minority Interest
38.89
34.70
31.00
40.69
23.07
22.79
19.18
12.17
9.16
9.07
7.49
Minority Interest
-0.17
-0.27
-1.83
0.87
2.55
0.76
0.01
0.30
0.29
0.19
0.12
PAT Margin
16.62%
16.06%
15.92%
23.34%
18.85%
19.13%
19.02%
13.76%
13.69%
14.22%
15.77%
PAT Growth
12.56%
18.03%
-29.81%
62.22%
8.79%
22.72%
53.89%
31.96%
2.05%
21.68%
 
EPS
45.95
40.51
34.32
48.89
30.14
27.71
22.58
14.67
11.12
10.89
8.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
228.31
201.07
177.46
140.63
121.95
101.71
84.92
75.01
67.30
59.76
Share Capital
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
8.51
5.67
Total Reserves
219.80
192.56
168.95
132.13
113.44
93.20
76.41
66.50
58.79
54.09
Non-Current Liabilities
113.72
96.64
69.64
44.41
48.32
41.28
37.66
20.46
16.31
6.15
Secured Loans
82.84
76.48
58.35
36.54
44.62
33.09
30.89
14.76
13.71
1.29
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.90
0.76
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
61.37
83.46
48.66
54.63
38.01
38.20
35.01
45.47
38.89
28.22
Trade Payables
28.09
20.02
8.75
7.90
7.47
5.84
4.63
4.52
5.71
4.06
Other Current Liabilities
22.52
30.44
17.15
20.26
11.04
9.30
6.35
7.41
8.84
4.21
Short Term Borrowings
3.28
32.54
22.50
25.41
18.32
21.04
20.08
29.74
16.08
12.73
Short Term Provisions
7.48
0.46
0.26
1.07
1.18
2.02
3.95
3.80
8.27
7.21
Total Liabilities
411.05
386.59
299.46
244.04
212.88
185.84
160.46
142.22
123.70
95.43
Net Block
132.76
142.54
144.82
110.22
102.62
64.63
59.60
53.82
37.73
39.39
Gross Block
228.12
226.04
215.94
170.22
152.95
108.25
97.57
86.69
65.25
62.49
Accumulated Depreciation
95.36
83.50
70.98
60.00
50.33
43.62
37.97
32.87
27.52
23.09
Non Current Assets
249.54
227.29
157.80
145.59
132.91
111.63
100.45
85.12
73.90
49.30
Capital Work in Progress
108.99
74.15
7.05
31.81
21.29
36.46
32.60
20.55
28.89
6.30
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.07
0.28
0.28
0.28
0.00
Long Term Loans & Adv.
4.98
6.74
4.34
3.48
8.52
10.47
7.97
10.47
7.00
3.60
Other Non Current Assets
2.81
3.87
1.58
0.08
0.47
0.00
0.00
0.00
0.00
0.00
Current Assets
161.51
159.31
141.66
98.45
79.97
74.20
60.00
57.10
49.80
46.12
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
62.22
63.97
50.79
39.76
33.41
33.62
29.11
35.59
31.10
27.56
Sundry Debtors
49.21
58.44
32.87
32.29
26.53
26.24
17.76
14.06
15.04
14.36
Cash & Bank
21.27
23.53
41.05
13.39
11.48
5.28
6.58
4.85
2.63
3.70
Other Current Assets
28.80
5.18
5.63
4.06
8.54
9.05
6.55
2.60
1.03
0.50
Short Term Loans & Adv.
26.24
8.19
11.32
8.95
5.06
2.49
6.55
2.60
1.03
0.50
Net Current Assets
100.14
75.84
92.99
43.82
41.95
36.00
25.00
11.63
10.91
17.90
Total Assets
411.05
386.60
299.46
244.04
212.88
185.83
160.45
142.22
123.70
95.42

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
58.05
36.77
46.71
38.02
34.80
18.85
19.76
9.39
11.54
14.16
PBT
50.10
41.33
56.86
36.12
30.93
24.81
18.20
13.37
14.41
11.90
Adjustment
22.66
20.13
17.92
13.63
10.86
9.38
7.34
11.91
7.67
6.75
Changes in Working Capital
-0.78
-13.75
-12.26
-2.31
0.11
-9.37
-0.33
-6.02
-5.04
-3.76
Cash after chg. in Working capital
71.99
47.71
62.52
47.44
41.90
24.82
25.21
19.25
17.04
14.89
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-13.94
-10.94
-15.81
-9.41
-7.06
-5.97
-5.45
-9.86
-5.50
-0.73
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
-0.04
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-38.37
-74.47
-21.73
-25.83
-30.19
-13.30
-21.21
-14.59
-22.55
-10.23
Net Fixed Assets
-0.70
-5.09
-11.03
-20.52
-15.30
-6.87
-12.04
-10.39
-20.32
-7.74
Net Investments
-3.21
-12.45
-13.74
-5.88
0.07
0.21
-5.25
-0.85
-0.28
0.00
Others
-34.46
-56.93
3.04
0.57
-14.96
-6.64
-3.92
-3.35
-1.95
-2.49
Cash from Financing Activity
-18.22
18.74
2.65
-11.08
1.83
-6.68
6.76
7.38
9.90
-1.84
Net Cash Inflow / Outflow
1.46
-18.96
27.63
1.12
6.45
-1.14
5.31
2.19
-1.12
2.10
Opening Cash & Equivalents
23.53
40.65
12.33
11.18
4.73
6.12
0.82
2.29
3.41
1.32
Closing Cash & Equivalent
21.27
23.53
40.65
12.33
11.18
4.99
6.12
4.48
2.29
3.41

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
268.38
236.36
208.61
165.32
143.35
119.56
96.86
88.18
79.11
70.25
ROA
8.70%
9.04%
14.97%
10.10%
11.43%
11.08%
8.06%
6.89%
8.28%
8.42%
ROE
16.16%
16.38%
25.59%
17.57%
20.38%
20.56%
15.46%
12.88%
14.28%
14.12%
ROCE
17.33%
16.53%
26.64%
20.20%
19.75%
18.98%
16.53%
17.78%
20.10%
20.27%
Fixed Asset Turnover
0.94
0.83
0.92
0.84
0.96
1.00
1.01
0.93
1.04
0.81
Receivable days
91.66
90.92
66.77
78.70
76.80
77.96
63.83
75.19
80.59
103.02
Inventory Days
107.45
114.27
92.80
97.89
97.55
111.14
127.14
172.29
160.79
187.67
Payable days
174.82
42.10
27.25
33.70
33.48
29.56
28.17
45.39
41.89
45.17
Cash Conversion Cycle
24.29
163.09
132.33
142.89
140.87
159.54
162.80
202.09
199.49
245.52
Total Debt/Equity
0.46
0.60
0.51
0.49
0.54
0.58
0.71
0.64
0.48
0.27
Interest Cover
8.59
6.61
9.57
9.95
9.84
7.67
4.52
3.07
5.41
5.21

News Update:


  • Hester Biosciences gets Rs 60 crore grant from BIRAC to support COVID-19 vaccine manufacturing
    8th Apr 2022, 11:16 AM

    Last year, a Memorandum of Understanding was inked between Bharat Biotech and Gujarat COVID Vaccine Consortium for the production of Covaxin

    Read More
  • Hester Biosciences to venture into pet care industry
    22nd Mar 2022, 14:36 PM

    The company’s initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and specialty products

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.